Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-8,024
Closed -$508K 1803
2025
Q1
$486K Buy
+8,024
New +$560K 0.01% 825
2024
Q4
Sell
-6,253
Closed -$413K 2016
2024
Q3
$413K Sell
6,253
-3,330
-35% -$212K 0.01% 1375
2024
Q2
$581K Buy
9,583
+3,659
+62% +$207K 0.01% 1057
2024
Q1
$337K Buy
+5,924
New +$356K 0.01% 1184
2023
Q1
Sell
-2,506
Closed -$201K 1666
2022
Q4
$201K Sell
2,506
-885
-26% -$67.7K 0.01% 1091
2022
Q3
$226K Buy
3,391
+353
+12% +$26.1K ﹤0.01% 1141
2022
Q2
$231K Buy
+3,038
New +$231K 0.01% 1225
2022
Q1
Sell
-3,621
Closed -$266K 1709
2021
Q4
$266K Buy
3,621
+645
+22% +$43.5K 0.01% 939
2021
Q3
$205K Sell
2,976
-27,216
-90% -$2.07M 0.01% 918
2021
Q2
$2.54M Buy
30,192
+18,972
+169% +$1.58M 0.06% 269
2021
Q1
$912K Buy
+11,220
New +$958K 0.03% 392
2020
Q2
Sell
-12,286
Closed -$899K 739
2020
Q1
$899K Buy
12,286
+9,327
+315% +$705K 0.04% 219
2019
Q4
$258K Buy
+2,959
New +$253K 0.01% 595

Other funds holding INCY

Centiva Capital's INCY Position: Q2 2025 in Review

Centiva Capital sold out of Incyte (INCY) in Q2 2025, closing a stake of 8,024 shares — an estimated $508K sold.

Centiva Capital first reported a position in INCY in Q4 2019 and held it in 13 quarters. The position peaked at $2.54M in Q2 2021. 658 funds tracked by Wall St. Rank hold INCY as of Q2 2025.

  • Centiva Capital reported no remaining Incyte position as of Q2 2025 after selling out during the quarter.
  • Centiva Capital sold 8,024 Incyte shares in Q2 2025, an estimated $508K.
  • Centiva Capital first reported a position in Incyte in Q4 2019 and held it in 13 quarters.
  • Centiva Capital's Incyte position peaked at $2.54M in Q2 2021.
  • 658 funds tracked by Wall St. Rank held Incyte as of Q2 2025.

Based on Centiva Capital's 13F filing for Q2 2025, filed 13 Aug 2025.